SCHEMBL730296

SCHEMBL730296

COc1c[c]cc(OC)c1-c1ccc(Cl)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.38
ALDH1A1 P00352 2/20 0.37
TP53 P04637 2/20 0.37
MAPT P10636 2/20 0.37
MAPK1 P28482 2/20 0.37
HTT P42858 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
LMNA P02545 1/20 0.37
POLB P06746 1/20 0.37
TSHR P16473 1/20 0.37
CXCL12 P48061 2/20 0.36
MDM2 Q00987 1/20 0.36
CNR1 P21554 1/20 0.36
RAB9A P51151 2/20 0.35
CRHR1 P34998 1/20 0.35
KDM4E B2RXH2 1/20 0.35
S1PR4 O95977 1/20 0.35
HSP90AA1 P07900 1/20 0.35
G6PD P11413 1/20 0.35
S1PR1 P21453 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL730765 0.82 CA12 (0.46) TP53MAPTMAPK1RAB9AKDM4E
SCHEMBL733076 0.82 ACHE (0.40) ALDH1A1MAPTPOLBRAB9AKDM4E
SCHEMBL3021896 0.81 ERN1 (0.41) ERN1ALDH1A1MEN1KMT2AGAA
SCHEMBL28451770 0.80 PDE4A (0.41) ALDH1A1MAPTMAPK1HTTLMNA
SCHEMBL733057 0.79 CA1 (0.44) ALDH1A1TP53MAPTMAPK1HTT
SCHEMBL733034 0.78 TSHR (0.43) TP53MAPTTSHRMEN1KMT2A
SCHEMBL5319410 0.78 GSK3A (0.40) CNR1CRHR1MEN1KMT2ACNR2
SCHEMBL8801058 0.76 PDE4A (0.50) ERN1ALDH1A1MAPTMAPK1HTT
SCHEMBL27588559 0.76 KMT2A (0.36) ERN1CXCL12MEN1KMT2A
SCHEMBL4410836 0.74 TSHR (0.44) ERN1ALDH1A1TP53MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2120569-B1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME (US) 2013-08-14 EP disclosed
US-8138197-B2 Spirochromanon derivatives MSD K.K. (JP) 2012-03-20 US disclosed
EP-2120569-A2 SPIROCHROMANON DERIVATIVES Merck & Co., Inc. (US) 2009-11-25 EP disclosed
US-20090270436-A1 SPIROCHROMANON DERIVATIVES MERCK SHARP & DOHME LLC 2009-10-29 US disclosed
WO-2008088692-A2 SPIROCHROMANON DERIVATIVES MERCK & CO., INC. (US) 2008-07-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270436-A1 SPIROCHROMANON DERIVATIVES AKR1C3, CBR3, AKR1C4 ERN1 719/4885ALDH1A1 113/4885TP53 2365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.